Summary: The brain depends on a continuous supply of energy to maintain neurotransmitter balance. New research shows that when energy runs low—such as during ischemia or stroke—neurons begin releasing glutamate in atypical, self-amplifying plume-like bursts. These events accumulate extracellular glutamate, triggering excitotoxic cascades that can damage or kill neurons and worsen neurological outcomes.
Scientists used a fluorescent glutamate sensor to watch extracellular glutamate in real time and found long-lasting, localized release events that became far more frequent under metabolic stress. The observations reveal a potentially dangerous feedback loop: energy failure favors abnormal glutamate plumes, which in turn promote further glutamate release and accumulation. Interventions that block ionotropic glutamate receptors—especially NMDA receptors—substantially reduced these harmful events.
Key Facts:
- Energy crisis: Loss of cellular energy disrupts the normal balance of glutamate release and uptake, favoring atypical release events.
- Toxic cascade: Elevated extracellular glutamate impairs synaptic function and can induce excitotoxic neuronal injury.
- Therapeutic clue: Inhibiting ionotropic glutamate receptors, particularly NMDA receptors, markedly decreased plume-like release activity.
Institution: Ruhr University Bochum (RUB), in collaboration with the Universities of Düsseldorf and Twente.
Researchers led by Dr. Tim Ziebarth (Cellular Neurobiology, Ruhr University Bochum) examined how metabolic stress alters glutamate signaling using mouse cortical slice cultures. They reported their findings in iScience on April 18, 2025. By applying the fluorescent glutamate reporter SF-iGluSnFR(A184V), the team could visualize extracellular glutamate dynamics with high spatial and temporal resolution.
Atypical plume-like glutamate events
Under healthy conditions, neurons release and clear glutamate in a tightly regulated cycle that supports synaptic communication. When energy supply drops—such as during chemical ischemia or stroke—this balance breaks down. Normal, action-potential–dependent synaptic release diminishes because vesicular release and uptake mechanisms require ATP. Simultaneously, the team observed infrequent but distinct local glutamate signals: large, long-lasting, and spatially heterogeneous plumes that were independent of typical network-driven activity.
These plumes occurred at low frequency under baseline conditions and persisted even after blocking action potentials with tetrodotoxin (TTX), indicating a release mechanism that does not depend on standard neuronal firing. When researchers deliberately induced metabolic stress, plume frequency and size rose dramatically and became a dominant contributor to overall extracellular glutamate accumulation.
Self-reinforcing accumulation and receptor involvement
Further experiments showed that elevated extracellular glutamate promotes additional plume events, establishing a self-reinforcing cycle: metabolic failure fosters plumes, which increase extracellular glutamate, which then drives more plumes. The researchers manipulated glutamate uptake and receptor signaling to probe mechanisms. Blocking glutamate transporters enhanced plume occurrence, while antagonists of ionotropic glutamate receptors suppressed plumes. The strongest suppression came from inhibitors targeting NMDA receptors, suggesting that receptor-mediated signaling amplifies the atypical release process.
Although the study clearly links metabolic stress to plume-like glutamate release and demonstrates that these events can be pharmacologically reduced, it does not yet pinpoint the exact cellular sources or the precise molecular pathway that produces plumes. The events were previously noted in models of cortical spreading depression and migraine, which suggests plume-like release might be a broader consequence of impaired glutamate clearance across several neurological conditions.
Professor Andreas Reiner emphasizes that while the detailed origins and full contribution of plume events to stroke or neurodegeneration need further study, the harmful effects of sustained extracellular glutamate are well established. By identifying a previously underappreciated release mode that becomes dominant during metabolic stress, this work highlights a potential target for interventions aimed at reducing excitotoxic damage after ischemic injury.
About this neuroscience research news
Author: Julia Weiler
Source: RUB (Ruhr University Bochum)
Contact: Julia Weiler, RUB
Image credit: Neuroscience News
Original Research (open access): Atypical Plume-Like Events Contribute to Glutamate Accumulation in Metabolic Stress Conditions. DOI: 10.1016/j.isci.2025.112256. Authors include Andreas Reiner et al., published in iScience.
Abstract (condensed)
Glutamate homeostasis is crucial for neural health. Ischemic and metabolic stress disrupt balance between release and uptake, promoting extracellular glutamate build-up. Using the SF-iGluSnFR glutamate sensor in mouse cortical slice cultures, researchers visualized spontaneous network-associated glutamate transients alongside distinct, local plume-like events that were large and long-lasting. Plumes appeared independently of action potentials, were favored by impaired uptake, and were suppressed by blocking ionotropic glutamate receptors. During chemical ischemia, plumes became frequent and contributed substantially to glutamate accumulation. Similar events appear in spreading depression and migraine models, indicating that plume-like release may be a general consequence of glutamate uptake dysfunction in diverse neurological conditions.